An observational study to evaluate the impact of waiting time in the blood testing and medical flow for cancer patients

An observational study to evaluate the impact of waiting time in the blood testing and medical flow for cancer patients - An observational study to evaluate the impact of waiting time in the blood testing and medical flow for cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055757

Enrollment

Registered

2024-10-07

Start date

2024-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.At least 18 years old at the time of obtaining consent 2.Cancer patients scheduled for or receiving systemic chemotherapy 3.Possible to visit research partner institutions that conduct blood sampling in advance 4.Can answer surveys 5.The principal investigator or research associate can determine that the investigator or research associate has the ability to understand and comply with the content of the clinical research 6.Able to sign and date ICF prior to enrollment in this study

Exclusion criteria

Exclusion criteria: 1.Patients receiving oral anticancer drugs only or hospitalized and not scheduled to use an outpatient chemotherapy unit 2.The principal investigator or principal research scientist determines that the subject is inappropriate.

Design outcomes

Primary

Measure	Time frame
Waiting time1 Time spent at the collaborating institution for preliminary blood test and waiting time from the start of reception to the start of consultation on the day of chemotherapy at the implementing institution. Waiting time2 Waiting time from the start of reception to the start of consultation on the day of chemotherapy at the implementing medical institution when blood test are not taken in advance.	—

Measure

Time frame

Waiting time1 Time spent at the collaborating institution for preliminary blood test and waiting time from the start of reception to the start of consultation on the day of chemotherapy at the implementing institution. Waiting time2 Waiting time from the start of reception to the start of consultation on the day of chemotherapy at the implementing medical institution when blood test are not taken in advance.

—

Countries

Japan

Contacts

Public ContactManami Onoue

St. Marianna University School of Medicine Department of Clinical Oncology

manami1o@marianna-u.ac.jp0449778111

Outcome results